Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1672 1678 1681 1777 1797
This examiner grants 79% of resolved cases
Maureen Wallenhorst is a high-volume examiner in Art Unit 1672, with 1414 resolved cases. The allowance rate of 78.9 percent indicates a favorable environment for patent grants within Tech Center 1700. This 78.9 percent rate suggests that the examiner is consistent and fair, allowing the vast majority of applications that properly define the invention over the prior art.
Efficiency is a key metric for this examiner, as shown by a median days to allowance of 791. This 791 day timeline is quite fast, especially considering the large volume of 1414 cases handled. While the interview lift is 5.8 percent, the strong baseline allowance rate suggests that the examiner is generally receptive to well-supported written arguments and that interviews may only be needed in exceptional circumstances.
Practitioners should aim for high-quality written submissions to take advantage of the 791 day efficiency. The 5.8 percent lift provides a small benefit, but the 78.9 percent allowance rate is the primary indicator of success. The large sample size of 1414 cases provides a high degree of confidence in these metrics, making this a predictable and efficient docket for patent applicants.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18736888 | Real Time Tack Quality Assessment for Unconsolidated Composite Materials | Non-Final OA | The Boeing Company |
| 18434924 | AUTOMATIC ANALYZER AND METHOD FOR DETECTING ADHESION OF LIQUID DROPLET TO PROBE | Non-Final OA | CANON KABUSHIKI KAISHA |
| 18402186 | Measuring Water Concentration in a Liquid Medium | Non-Final OA | Saudi Arabian Oil Company |
| 18533857 | SYSTEMS FOR AUTOMATED CONTROL OF FLUIDIC DEVICES AND METHODS THEREOF | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 17774338 | DIAGNOSIS AND TREATMENT OF NAFLD AND LIVER FIBROSIS | Non-Final OA | Beth Israel Deaconess Medical Center, Inc. |
| 18339760 | AUTOMATED CLINICAL DIAGNOSTIC SYSTEM AND METHOD | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 18206447 | SYSTEMS FOR RECONSTITUTING DRIED REAGENT COMPOSITIONS AND METHODS FOR USING THE SAME | Non-Final OA | Becton, Dickinson and Company |
| 18389287 | METHOD FOR DETERMINING PROSTATE CANCER | Final Rejection | HAMAMATSU PHOTONICS K.K. |
| 18491622 | LABORATORY INSTRUMENT | Final Rejection | Roche Molecular Systems, Inc. |
| 18214232 | TUNNELING JUNCTIONS FOR SEQUENCING | Final Rejection | Roche Sequencing Solutions, Inc. |
| 17641689 | METHOD AND KIT FOR QUANTIFICATION OF SMALL, DENSE LDL CHOLESTEROL | Non-Final OA | Denka Company Limited |
| 17950415 | IRON MITIGATION ZINC MEASUREMENT | Non-Final OA | Hach Company |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy